logo

AEMD

Aethlon Medical·NASDAQ
--
--(--)
--
--(--)

AEMD fundamentals

Aethlon Medical (AEMD) released its earnings on Feb 12, 2026: revenue was 0 (YoY --), met estimates; EPS was -2.45 (YoY +76.44%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-2.45
+76.44%
Report date
Feb 12, 2026
AEMD Earnings Call Summary for Q3,2026
  • Trial Momentum: Cohort 2 nearing completion with 2 treatments; DSMB review in late March could pave way for Cohort 3.
  • Cost Efficiency: 27% YoY reduction in 9-month expenses; $7 million cash balance supports operations.
  • Innovation Focus: Exploring EV removal in autoimmune diseases and simplifying treatment via SLAMB system.
  • Strategic Clarity: Prioritizing Australia trial completion over global expansion.

Earnings

EPS
Revenue

Revenue & Expenses

Key Indicators

Aethlon Medical (AEMD) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Aethlon Medical (AEMD)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Aethlon Medical (AEMD)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Aethlon Medical (AEMD)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Aethlon Medical (AEMD) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Aethlon Medical (AEMD) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield